43598-426Level 3
Bortezomib (Bortezomib)
**Product type:** Human Prescription Drug
**Active ingredient:** BORTEZOMIB
**Strength:** 3.5 mg/1
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intravenous; Subcutaneous
**Labeler:** Dr.Reddy's Laboratories, Inc.
**Marketing category:** ANDA (ANDA202963)
**Pharmacologic class:** Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/43598-426Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.